Mckinley Capital Management LLC Sage Therapeutics, Inc. Transaction History

Mckinley Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 07, 2019	SELL	$157.85 - $183.09 $44,513 - $51,631	-282 Closed	0 $0
Q1 2019 May 02, 2019	BUY	$89.33 - $163.65 $8,754 - $16,037	98 Added 53.26%	282 $45,000
Q4 2018 Feb 11, 2019	SELL	$81.94 - $139.71 $17,944 - $30,596	-219 Reduced 54.34%	184 $18,000
Q3 2018 Nov 08, 2018	SELL	$138.11 - $169.04 $4,833 - $5,916	-35 Reduced 7.99%	403 $57,000
Q2 2018 Jul 13, 2018	SELL	$140.36 - $175.76 $5,193 - $6,503	-37 Reduced 7.79%	438 $69,000
Q1 2018 May 04, 2018	BUY	$152.15 - $192.33 $72,271 - $91,356	475 New	475 $76,000

218

48.2M

854K

195K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $415M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Mckinley Capital Management LLC , based on Form 13F filings with the SEC.

Stay updated on Mckinley Capital Management LLC with notifications on news.